CDKN2A and melanoma: The major melanoma-susceptibility gene is CDKN2A, coding for two alternatively transcribed mRNAs translated into the cyclin-dependent kinase inhibitor p16INK4 and the tumor suppressor p14ARF participating in p53 activation, respectively [7].